Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses

p53 protects against cancer through its capacity to induce cell cycle arrest or apoptosis under a large variety of cellular stresses. It is not known how such diversity of signals can be integrated by a single molecule. However, the literature reveals that a common denominator in all p53‐inducing stresses is nucleolar disruption. We thus postulated that the impairment of nucleolar function might stabilize p53 by preventing its degradation. Using micropore irradiation, we demonstrate that large amounts of nuclear DNA damage fail to stabilize p53 unless the nucleolus is also disrupted. Forcing nucleolar disruption by anti‐upstream binding factor (UBF) microinjection (in the absence of DNA damage) also causes p53 stabilization. We propose that the nucleolus is a stress sensor responsible for maintenance of low levels of p53, which are automatically elevated as soon as nucleolar function is impaired in response to stress. Our model integrates all known p53‐inducing agents and also explains cell cycle‐related variations in p53 levels which correlate with established phases of nucleolar assembly/disassembly through the cell cycle.

[1]  K. Jakobs,et al.  Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  Chunyi Zhang,et al.  A role for Rho in receptor- and G protein-stimulated phospholipase C Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  K. Jakobs,et al.  Differential calcium signalling by m2 and m3 muscarinic acetylcholine receptors in a single cell type , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

[4]  U. Kutay,et al.  Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway , 2003, Journal of Cell Science.

[5]  J. Milner,et al.  p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage , 2003, The EMBO journal.

[6]  J. Borowiec,et al.  Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation , 2002, Molecular and Cellular Biology.

[7]  Pier Giuseppe Pelicci,et al.  Nucleophosmin regulates the stability and transcriptional activity of p53 , 2002, Nature Cell Biology.

[8]  Yili Yin,et al.  p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products , 2002, Nature Cell Biology.

[9]  U. Moll,et al.  Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Mann,et al.  Directed Proteomic Analysis of the Human Nucleolus , 2002, Current Biology.

[11]  J. Hiscox,et al.  The nucleolus – a gateway to viral infection? , 2002, Archives of Virology.

[12]  R. Iggo,et al.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Hainaut,et al.  Genotoxic and non-genotoxic pathways of p53 induction. , 2001, Cancer letters.

[14]  J. Weitzman Light-induced apoptosis , 2001, Genome Biology.

[15]  M. J. Moné,et al.  Local UV‐induced DNA damage in cell nuclei results in local transcription inhibition , 2001, EMBO reports.

[16]  D. Lane,et al.  Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. , 2001, Experimental cell research.

[17]  P. Roussel,et al.  Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells , 2001, Oncogene.

[18]  Lester F. Lau,et al.  Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition , 2001, Molecular and Cellular Biology.

[19]  H. O’Hagan,et al.  Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress. , 2001, Journal of cell science.

[20]  K. Tsai,et al.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 , 2000, Nature Cell Biology.

[21]  L. Comai,et al.  Repression of RNA Polymerase I Transcription by the Tumor Suppressor p53 , 2000, Molecular and Cellular Biology.

[22]  M. Ljungman Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. , 2000, Neoplasia.

[23]  J. D. Weber,et al.  The ARF/p53 pathway. , 2000, Current opinion in genetics & development.

[24]  D. Meek,et al.  Mechanisms of switching on p53: a role for covalent modification? , 1999, Oncogene.

[25]  T. David-Pfeuty Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells , 1999, Oncogene.

[26]  A. Levine,et al.  P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  I. Grummt,et al.  Cell cycle-dependent regulation of RNA polymerase I transcription: the nucleolar transcription factor UBF is inactive in mitosis and early G1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Wahl,et al.  A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.

[29]  P. Herrlich,et al.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation , 1999, Oncogene.

[30]  A. Budde,et al.  p53 represses ribosomal gene transcription , 1999, Oncogene.

[31]  F. Chen,et al.  Inhibition of RNA polymerase II as a trigger for the p53 response , 1999, Oncogene.

[32]  I. Grummt,et al.  Cell cycle-dependent regulation of RNA polymerase I transcription : The nucleolar transcription factor UBF is inactive in mitosis and early G 1 , 1999 .

[33]  A. Levine,et al.  Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6 , 1998, Molecular and Cellular Biology.

[34]  Kevin Ryan,et al.  The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2 , 1998, The EMBO journal.

[35]  P. Jordan,et al.  Cisplatin inhibits synthesis of ribosomal RNA in vivo. , 1998, Nucleic acids research.

[36]  Robert J White,et al.  p53 is a general repressor of RNA polymerase III transcription , 1998, The EMBO journal.

[37]  L. Donehower,et al.  Murine tumor suppressor models. , 1998, Mutation research.

[38]  L. Mullenders,et al.  Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes. , 1998, Mutation research.

[39]  J. Hauber,et al.  Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Levine,et al.  Nucleo‐cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein , 1998, The EMBO journal.

[41]  S. Takasawa,et al.  Muscarinic Receptor-mediated Dual Regulation of ADP-ribosyl Cyclase in NG108-15 Neuronal Cell Membranes* , 1997, Journal of Biological Chemistry.

[42]  T. Wieland,et al.  Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[43]  B. Wasylyk,et al.  Transcription Abnormalities Potentiate Apoptosis of Normal Human Fibroblasts , 1997, Molecular medicine.

[44]  David P. Lane,et al.  Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo , 1997, Current Biology.

[45]  J. Putney,et al.  Role of the Cytoskeleton in Calcium Signaling in NIH 3T3 Cells , 1997, The Journal of Biological Chemistry.

[46]  K. Mikoshiba The InsP3 receptor and intracellular Ca2+ signaling , 1997, Current Opinion in Neurobiology.

[47]  B. Fontoura,et al.  Cytoplasmic p53 polypeptide is associated with ribosomes , 1997, Molecular and cellular biology.

[48]  T. Kurosaki,et al.  Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5‐trisphosphate receptors in signal transduction through the B‐cell antigen receptor , 1997, The EMBO journal.

[49]  J. Blaydes,et al.  Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2 , 1997, Oncogene.

[50]  C. Potten,et al.  Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[52]  G. S. Johnson,et al.  An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.

[53]  D. Evans,et al.  Li-Fraumeni syndrome--a molecular and clinical review. , 1997, British Journal of Cancer.

[54]  Yan Liu,et al.  Heat shock disassembles the nucleolus and inhibits nuclear protein import and poly(A)+ RNA export. , 1996, The EMBO journal.

[55]  Duane D. Miller,et al.  A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1‐phosphate in atrial myocytes. , 1996, The EMBO journal.

[56]  M. Ljungman,et al.  Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. , 1996, Oncogene.

[57]  M. Beaven Calcium signalling: Sphingosine kinase versus phospholipase C? , 1996, Current Biology.

[58]  L. Strong,et al.  Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. , 1996, Oncogene.

[59]  K. Jalink,et al.  Sphingosine‐1‐phosphate rapidly induces Rho‐dependent neurite retraction: action through a specific cell surface receptor. , 1996, The EMBO journal.

[60]  J. Kinet,et al.  Calcium mobilization via sphingosine kinase in signalling by the FcɛRI antigen receptor , 1996, Nature.

[61]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[62]  D C Ward,et al.  Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains. , 1996, Experimental cell research.

[63]  Y. Pommier,et al.  RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. , 1996, Cancer research.

[64]  Y. Qi,et al.  Quantitation of the nucleophosmin/B23-translocation using imaging analysis. , 1996, Cancer letters.

[65]  Chunyi Zhang,et al.  Activation of a High Affinity G Protein-coupled Plasma Membrane Receptor by Sphingosine-1-phosphate (*) , 1996, The Journal of Biological Chemistry.

[66]  S. Hakomori,et al.  N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. , 1996, Biochemistry.

[67]  J. Exton Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. , 1996, Annual review of pharmacology and toxicology.

[68]  A. Kristjuhan,et al.  Protein p53 modulates transcription from a promoter containing its binding site in a concentration-dependent manner. , 1995, European journal of biochemistry.

[69]  P. Hanawalt,et al.  Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Krebs,et al.  Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction , 1995, The Journal of cell biology.

[71]  H. Boddeke,et al.  Heparin‐insensitive calcium release from intracellular stores triggered by the recombinant human parathyroid hormone receptor , 1995, British journal of pharmacology.

[72]  S. Rhee,et al.  Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. , 1995, Current opinion in cell biology.

[73]  A. Levine,et al.  The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes , 1994, Molecular and cellular biology.

[74]  T. Sugano,et al.  U.v.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. , 1994, Oncogene.

[75]  D. Gill,et al.  Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. , 1994, The Journal of biological chemistry.

[76]  T. Graeber,et al.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.

[77]  S. Spiegel,et al.  Stereospecificity of sphingosine-induced intracellular calcium mobilization and cellular proliferation. , 1994, The Journal of biological chemistry.

[78]  S. Spiegel,et al.  Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. , 1994, The Journal of biological chemistry.

[79]  K. Ghoshal,et al.  Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil. , 1994, Cancer research.

[80]  S. Spiegel,et al.  Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens , 1993, Nature.

[81]  P. Hanawalt,et al.  Lack of transcription-coupled repair in mammalian ribosomal RNA genes. , 1993, Biochemistry.

[82]  P. Vigne,et al.  ADP induces inositol phosphate-independent intracellular Ca2+ mobilization in brain capillary endothelial cells. , 1993, The Journal of biological chemistry.

[83]  M. Berridge Inositol trisphosphate and calcium signalling , 1993, Nature.

[84]  S. Cockcroft,et al.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. , 1992, The Biochemical journal.

[85]  B. Fontoura,et al.  p53 is covalently linked to 5.8S rRNA , 1992, Molecular and cellular biology.

[86]  R. Bell,et al.  Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways. , 1992, The Journal of biological chemistry.

[87]  B. Yung,et al.  Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line , 1991, International journal of cancer.

[88]  R. Carroll,et al.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage , 1991, Molecular and cellular biology.

[89]  D. Gill,et al.  Intracellular calcium release mediated by sphingosine derivatives generated in cells. , 1990, Science.

[90]  S. Hakomori,et al.  Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. , 1989, Biochemistry.

[91]  H. Motulsky,et al.  Alpha 2-adrenergic receptor stimulation mobilizes intracellular Ca2+ in human erythroleukemia cells. , 1989, The Journal of biological chemistry.

[92]  Y. Chentsov,et al.  Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells. , 1989, Experimental cell research.

[93]  M. Berridge,et al.  Subsecond and second changes in inositol polyphosphates in GH4C1 cells induced by thyrotropin-releasing hormone. , 1987, The Biochemical journal.

[94]  J. Pédron,et al.  Ultrastructural and autoradiographic study of the effects of bleomycin on the interphase nucleus of cultured normal cells. , 1979, Cancer research.

[95]  I. T. Young Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[96]  A. Kisic,et al.  Sphingolipid base metabolism. Partial purification and properties of sphinganine kinase of brain. , 1976, The Journal of biological chemistry.

[97]  F. Grummt,et al.  Control of nucleolar RNA synthesis by the intracellular pool sizes of ATP and GTP , 1976, Cell.